• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮动脉导管未闭封堵术:多中心注册研究比较多种封堵器。

Percutaneous closure of patent ductus arteriosus: a multiinstitutional registry comparing multiple devices.

机构信息

Department of Anesthesiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Catheter Cardiovasc Interv. 2010 Nov 1;76(5):696-702. doi: 10.1002/ccd.22538.

DOI:10.1002/ccd.22538
PMID:20690153
Abstract

BACKGROUND

There are no guidelines and multiple devices available now for closure of PDA.

OBJECTIVE

We sought to determine which devices are used and their outcomes.

METHODS

Prospectively collected data on closure of PDA at 12 US catheterization labs was entered into the MAGIC data registry between November 2005 and September 2008.

RESULTS

PDA closure was accomplished in 357 of 359 attempted closures during the study period. Mean age, weight, and minimum ductal diameter were 4.3 ± 6.8 years, 18.7 ± 18.4 kg, and 2.1 ± 1.4 mm, respectively. Devices used were Gianturco coils (161/359), Amplatzer Duct Occluder (ADO, 174/359), Flipper coils (18/359), and other devices (6/359). Gianturco coils had the least fluoroscopy and contrast exposure (8.7 ± 7.5 min, P = 0.00001, 2.6 ± 1.4 cm(3) kg(-1), P = 0.00001). Immediate angiographic success rates were 96.9% (156/161) for Gianturco coils, 89.7% (156/174) for the ADO, 100% (18/18) for Flipper coils, and 66.7% (4/6) for other devices. Major complication rates were 0.6% for Gianturco coils (1/161), 1.7% for ADO (3/174), and 83.3% for other devices (4/6). Minor complication rates by device were 1.9% for Gianturco coils (3/161), 2.3% for ADO (4/174), and 16.7% (1/6) for other devices.

CONCLUSIONS

Gianturco coils, the ADO and Flipper coils were immediately successful with low complication profiles. The ADO and Gianturco coils were the predominate devices. The ADO was the device of choice for PDA > 3 mm with good success. In PDA < 3 mm, the Gianturco coil is as effective and safe as the ADO with less cost, less radiation, and less contrast exposure. © 2010 Wiley-Liss, Inc.

摘要

背景

目前尚无关于动脉导管未闭(PDA)封堵的指南,也有多种封堵设备可供选择。

目的

我们旨在确定目前封堵 PDA 所使用的设备及其结果。

方法

2005 年 11 月至 2008 年 9 月,在 12 个美国导管实验室前瞻性收集 PDA 封堵的数据,并录入 MAGIC 数据登记处。

结果

在研究期间,359 次尝试封堵中有 357 次成功。平均年龄、体重和最小动脉导管直径分别为 4.3±6.8 岁、18.7±18.4kg 和 2.1±1.4mm。使用的封堵设备包括 Gianturco 线圈(161/359)、Amplatzer 动脉导管未闭封堵器(ADO,174/359)、Flipper 线圈(18/359)和其他设备(6/359)。Gianturco 线圈的透视和造影剂暴露最少(8.7±7.5min,P=0.00001;2.6±1.4cm3/kg,P=0.00001)。Gianturco 线圈即刻血管造影成功率为 96.9%(156/161),ADO 为 89.7%(156/174),Flipper 线圈为 100%(18/18),其他设备为 66.7%(4/6)。Gianturco 线圈的主要并发症发生率为 0.6%(1/161),ADO 为 1.7%(3/174),其他设备为 83.3%(4/6)。Gianturco 线圈的次要并发症发生率为 1.9%(3/161),ADO 为 2.3%(4/174),其他设备为 16.7%(1/6)。

结论

Gianturco 线圈、ADO 和 Flipper 线圈即刻成功率高,并发症发生率低。ADO 和 Gianturco 线圈是主要的封堵设备。对于直径>3mm 的 PDA,ADO 是首选封堵设备,其成功率较高。对于直径<3mm 的 PDA,Gianturco 线圈与 ADO 同样有效且安全,但其费用更低、辐射更少、造影剂暴露更少。

相似文献

1
Percutaneous closure of patent ductus arteriosus: a multiinstitutional registry comparing multiple devices.经皮动脉导管未闭封堵术:多中心注册研究比较多种封堵器。
Catheter Cardiovasc Interv. 2010 Nov 1;76(5):696-702. doi: 10.1002/ccd.22538.
2
Trans-catheter closure of patent ductus arteriosus-What is the best device?经导管动脉导管未闭封堵术——哪种封堵器最好?
Catheter Cardiovasc Interv. 2010 Nov 1;76(5):687-95. doi: 10.1002/ccd.22393.
3
Comparison of the results of transcatheter closure of patent ductus arteriosus with newer Amplatzer devices.比较新型 Amplatzer 封堵器经导管治疗动脉导管未闭的效果。
Catheter Cardiovasc Interv. 2013 Aug 1;82(2):253-9. doi: 10.1002/ccd.24768. Epub 2013 Feb 21.
4
Cardi-O-Fix duct occluder versus Amplatzer duct occluder for closure of patent ductus arteriosus.Cardi-O-Fix封堵器与Amplatzer封堵器用于动脉导管未闭封堵的比较
Catheter Cardiovasc Interv. 2013 Nov 15;82(6):961-7. doi: 10.1002/ccd.24957. Epub 2013 Aug 9.
5
Comparison of two transcatheter device strategies for occlusion of the patent ductus arteriosus.两种经导管装置策略封堵动脉导管未闭的比较。
Catheter Cardiovasc Interv. 2008 Nov 1;72(5):675-80. doi: 10.1002/ccd.21669.
6
Clinical evaluation of the new Amplatzer duct occluder II for patent arterial duct occlusion.新型 Amplatzer 动脉导管未闭封堵器 II 的临床评估。
Catheter Cardiovasc Interv. 2009 Nov 1;74(5):762-9. doi: 10.1002/ccd.22095.
7
Transcatheter patent ductus arteriosus closure with echocardiographic guidance: can radiation exposure be reduced?超声心动图引导下经导管动脉导管未闭封堵术:能否减少辐射暴露?
Turk Kardiyol Dern Ars. 2014 Oct;42(7):643-50. doi: 10.5543/tkda.2014.71609.
8
Transcatheter closure of patent ductus arteriosus using the AMPLATZER™ duct occluder II (ADO II).使用AMPLATZER™动脉导管封堵器II(ADO II)经导管闭合动脉导管未闭。
Catheter Cardiovasc Interv. 2017 May;89(6):1118-1128. doi: 10.1002/ccd.26968. Epub 2017 Mar 4.
9
Percutaneous closure of patent ductus arteriosus in children using amplatzer duct occluder II: relationship between PDA type and risk of device protrusion into the descending aorta.使用Amplatzer II型动脉导管封堵器经皮封堵小儿动脉导管未闭:动脉导管未闭类型与封堵器突入降主动脉风险的关系
Catheter Cardiovasc Interv. 2015 Aug;86(2):E66-72. doi: 10.1002/ccd.25940. Epub 2015 May 29.
10
Closure of patent ductus arteriosus in children, small infants, and premature babies with Amplatzer duct occluder II additional sizes: multicenter study.应用 Amplatzer 动脉导管未闭封堵器 II 型附加型号对儿童、小婴儿和早产儿的动脉导管未闭进行封堵:多中心研究。
Catheter Cardiovasc Interv. 2013 Aug 1;82(2):245-52. doi: 10.1002/ccd.24905. Epub 2013 Apr 8.

引用本文的文献

1
Surgical treatment for patent ductus arteriosus in adult patients: a single center experience.动脉导管未闭患者的手术治疗:单中心经验。
Rom J Morphol Embryol. 2022 Oct-Dec;63(4):633-638. doi: 10.47162/RJME.63.4.05.
2
Safety and efficacy of percutaneous patent ductus arteriosus closure: a multicenter Egyptian experience.经皮动脉导管未闭封堵术的安全性和有效性:埃及多中心经验
Egypt Heart J. 2022 Mar 4;74(1):14. doi: 10.1186/s43044-022-00251-3.
3
The Outcome of Trans-catheter Closure of Patent Ductus Arteriosus: A Single-Center Experience.
动脉导管未闭经导管封堵术的疗效:单中心经验
Cureus. 2022 Jan 24;14(1):e21577. doi: 10.7759/cureus.21577. eCollection 2022 Jan.
4
Physiological fetal vascular shunts and failure to regress: what the radiologist needs to know.生理性胎儿血管交通及未能退化:放射科医师须知。
Pediatr Radiol. 2022 Jun;52(7):1207-1223. doi: 10.1007/s00247-022-05302-0. Epub 2022 Feb 15.
5
Hemolysis and its outcome following percutaneous closure of cardiac defects among children and adolescents: a prospective study.经皮心脏缺损封堵术后儿童和青少年的溶血及其结局:一项前瞻性研究。
Ital J Pediatr. 2019 Oct 18;45(1):128. doi: 10.1186/s13052-019-0728-5.
6
Percutaneous closure of patent ductus arteriosus with the Nit-Occlud patent ductus arteriosus device in 268 consecutive cases.使用Nit-Occlud动脉导管封堵器经皮闭合268例连续性动脉导管未闭病例。
Ann Pediatr Cardiol. 2019 Sep-Dec;12(3):206-211. doi: 10.4103/apc.APC_151_18.
7
Transcatheter Closure of Arterial Duct in Infants < 6 kg: Amplatzer Duct Occluder Type I vs Amplatzer Duct Occluder II Additional Sizes.体重<6kg婴儿动脉导管的经导管封堵:I型Amplatzer动脉导管封堵器与II型Amplatzer动脉导管封堵器及其他尺寸型号对比
Pediatr Cardiol. 2018 Mar;39(3):627-632. doi: 10.1007/s00246-018-1828-5. Epub 2018 Feb 17.
8
Cost-effectiveness analysis of devices for closure of patent ductus arteriosus.动脉导管未闭封堵装置的成本效益分析
Ann Pediatr Cardiol. 2018 Jan-Apr;11(1):109. doi: 10.4103/apc.APC_131_17.
9
Recent advances in pediatric interventional cardiology.儿科介入心脏病学的最新进展。
Korean J Pediatr. 2017 Aug;60(8):237-244. doi: 10.3345/kjp.2017.60.8.237. Epub 2017 Aug 14.
10
Initial experience with the 3.3 Fr Mongoose pigtail catheter for aortic angiography during patent ductus arteriosus closure in small patients.在小患者动脉导管未闭封堵术中使用3.3 Fr 獴猪尾导管进行主动脉血管造影的初步经验。
Ann Pediatr Cardiol. 2017 Sep-Dec;10(3):240-244. doi: 10.4103/apc.APC_9_17.